论文部分内容阅读
目的:观察并分析将盐酸左氧氟沙星用于妇科盆腔炎的疗效与安全性。方法:选取2014年7月~2015年7月之间于我院妇科接受治疗的盆腔炎患者100例,将其随机分为观察组与对照组,每组各50例,前者静脉滴注盐酸左氧氟沙星治疗,后者静滴氧氟沙星治疗,比较两组的临床疗效与不良反应情况。结果:经过治疗,观察组的痊愈率为62.0%,总有效率为94.0%,均高于对照组(痊愈率为94.0%,总有效率为62.0%),住院期间的不良反应发生率为6.0%,高于对照组(30.0%),差异显著,P<0.05,具有统计学意义。结论:在妇科盆腔炎的治疗中,应用盐酸左氧氟沙星能够尽快改善临床症状和体征,且无严重不良反应,安全性高,疗效显著,值得推广。
Objective: To observe and analyze the efficacy and safety of levofloxacin hydrochloride for gynecologic pelvic inflammatory disease. Methods: 100 patients with pelvic inflammatory disease undergoing gynecology in our hospital from July 2014 to July 2015 were randomly divided into observation group and control group, with 50 cases in each group. The former received intravenous infusion of levofloxacin hydrochloride The latter was treated with ofloxacin. The clinical efficacy and adverse reactions of the two groups were compared. Results: After treatment, the cure rate of the observation group was 62.0%, the total effective rate was 94.0%, higher than the control group (the cure rate was 94.0%, the total effective rate was 62.0%), and the incidence of adverse reactions during hospitalization was 6.0 %, Higher than the control group (30.0%), the difference was significant, P <0.05, with statistical significance. Conclusion: Levofloxacin hydrochloride can improve clinical symptoms and signs as soon as possible in the treatment of gynecologic pelvic inflammatory disease without serious adverse reactions, which is safe, effective and worthy of promotion.